COMPANY BACKGROUND:
Our Client, an Israeli corporation with offices in Tel Aviv, Israel, and Plymouth Meeting, Pennsylvania, pursues creative, unbeaten paths for the identification, development and commercialization of therapeutics for impairing CNS disorders. The company plans to develop and commercialize proprietary pharmaceutical products for the treatment of central nervous system disorders, and cognitive dysfunctions in particular.